The role of concomitant immunosuppressants in impeding the progression of diabetic retinopathy: A pilot study

PURPOSE: Hallmark of Diabetic Retinopathy (DR) is blood-retinal barrier alteration. Vascular endothelial growth factor (VEGF) and inflammation are involved in the pathogenesis of DR. Anti-VEGFs and lasers are effective in treating DR but have numerous drawbacks, hence the need to develop alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Raman, Premnath, Kathare, Rupal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725116/
https://www.ncbi.nlm.nih.gov/pubmed/34708796
http://dx.doi.org/10.4103/ijo.IJO_837_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725116/
https://www.ncbi.nlm.nih.gov/pubmed/34708796
http://dx.doi.org/10.4103/ijo.IJO_837_21

Ejemplares similares